Categories: Wire Stories

World First Dual Wave RF Micro-needling System: Sylfirm X is Recognized by TOP US Aesthetic Dermatologists

SEOUL, South Korea–(BUSINESS WIRE)–#SylfirmXVIOL Co., Ltd hosted the first global event called �Moonlight Sylfirm X Global Symposium 2022” on September 18th, at the Grand Mercure Hotel, Seoul. The Symposium invited renowned domestic aesthetic dermatologists and Top US board-certified plastic surgeons, bringing together a total of 100 aesthetic practitioners in one place. The Symposium Program was composed of lectures on scientific background and the unique discovery of Sylfirm X technology.


Among international speakers, American board-certified dermatologist, Dr. E. Victor Ross M.D. gave a presentation on “New Developments in RF Micro-needling- Pigment, the Next Frontier” and American board-certified plastic surgeon Diane Duncan M.D., “Biostimulation: Combining Sylfirm X with Biologicals” on revolutionary RF micro-needling technology and optimized safety of Sylfirm X with the “NA EFFECT.” Additionally, Miami Florida-based F.A.C.S plastic surgeon Dr. Randy Miller M.D and celebrity cosmetic surgeon & F.A.C.S Dr. Chad Deal shared their experiences with the fellow doctors during the event.

Dr. Miller said, “SYLFIRM X technology makes every other RF micro-needling device obsolete. Instantaneous results, no downtime and no anesthesia needed.” Domestic skin experts in the aesthetic field exchanged their research results and shared discovered treatment solutions with SYLFIRM X.

According to doctors, Sylfirm X’s world-first dual wave energy delivering method is a phenomenon that helps to improve skin textures and has strong effectiveness for facial redness compared to conventional RF delivering systems. Current user doctors are very satisfied with Sylfirm X generating minimal pain and downtime to overcome patients’ discomfort.

Dr. Chad Deal, a skin expert and board-certified plastic surgeon, said, “This right here is the single most amazing piece of aesthetic equipment I have ever seen in my 13 years of being in the operating room.”

Sylfirm X is the world’s first FDA-cleared Pulsed Wave (PW) and Continuous Wave (CW) Radio Frequency Micro Needling device that targets both skin laxity and pigmentation. It was developed by Dr. Ph.D. Jongju Na, based on the scientific report “Na Effect Phenomenon” published by Nature Publishing Group, describes independent thermal coagulation around each electrode. Sylfirm X adopted a bipolar non-insulated micro needle to maximize the treatment results specifically for vascular pigmentation during the PW modes, and skin revitalization during the CW modes.

For more information, please visit www.violmedical.com

Contacts

VIOL Co., Ltd

Jane Kim, Marketing Manager

+82.31.8017.7893

info@scarletrf.com

Alex

Recent Posts

The “ANDPAD” Cloud-Based Construction Project Management Service Adds Supporting Indonesian, Thai, Traditional Chinese (Taiwan), and Spanish Languages

TOKYO, JAPAN – Media OutReach Newswire – 16 December 2025 - ANDPAD Inc. (Headquarters: Minato…

39 minutes ago

Madame Tussauds Hong Kong Welcomes a New K-Wave Star Jung Hae In’s First-Ever Wax Figure Unveiled

HONG KONG SAR - Media OutReach Newswire - 16 December 2025 - Madame Tussauds Hong…

54 minutes ago

Southeast Asian Games Thailand 2025 Esports Appoints Moonshot as Official Mobile Controller Partner

SINGAPORE - Media OutReach Newswire - 16 December 2025 - Moonshot, a next-generation phygital mobile…

54 minutes ago

Zuellig Pharma expands partnership with Lundbeck to support commercialization of neuro-psychiatric health solutions in Asia

SINGAPORE - Media OutReach Newswire - 16 December 2025 - Zuellig Pharma, a leading healthcare…

54 minutes ago

St. George’s University and Dwight School Seoul Announce Affiliation, Offering Korean Students an International Medical Education

SEOUL, SOUTH KOREA - Media OutReach Newswire - 16 December 2025 - St. George’s University…

2 hours ago

Hong Kong High Court Convicts Lai Chee-Ying of Collusion to Endanger National Security

HONG KONG SAR - Media OutReach Newswire - 15 December 2025 - The Court of…

11 hours ago